Form 4 for HQL abrdn Life Sciences Investors
Accepted 2024-05-31 00:00:00 ET · period of report 2024-05-28 · accession 0001510281-24-000312 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-31 | 2024-05-28+ | HQL | Weinstein Boaz | 10% | P - Purchase | $13.14 | +47.4K | 3.26M | +1% | +$623.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-30 | P | A | 669 | $13.05 | 3,299,299 | I - | — | — | |
| 2 | Common | Common Stock | 2024-05-29 | P | A | 38,033 | $13.09 | 3,298,630 | I - | — | — | |
| 3 | Common | Common Stock | 2024-05-28 | P | A | 8,714 | $13.38 | 3,260,597 | I - | — | — |